High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains of Mycobacterium tuberculosis
- 1 February 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 1 (1), 43-53
- https://doi.org/10.1021/cb0500042
Abstract
Novel chemotherapeutics for treating multidrug-resistant (MDR) strains of Mycobacterium tuberculosis (MTB) are required to combat the spread of tuberculosis, a disease that kills more than 2 million people annually. Using structure-based drug design, we have developed a series of alkyl diphenyl ethers that are uncompetitive inhibitors of InhA, the enoyl reductase enzyme in the MTB fatty acid biosynthesis pathway. The most potent compound has a K′i value of 1 nM for InhA and MIC99 values of 2–3 µg mL−1 (6–10 µM) for both drug-sensitive and drug-resistant strains of MTB. Overexpression of InhA in MTB results in a 9–12-fold increase in MIC99, consistent with the belief that these compounds target InhA within the cell. In addition, transcriptional response studies reveal that the alkyl diphenyl ethers fail to upregulate a putative efflux pump and aromatic dioxygenase, detoxification mechanisms that are triggered by the lead compound triclosan. These diphenyl ether-based InhA inhibitors do not require activation by the mycobacterial KatG enzyme, thereby circumventing the normal mechanism of resistance to the front line drug isoniazid (INH) and thus accounting for their activity against INH-resistant strains of MTB.Keywords
This publication has 48 references indexed in Scilit:
- Inhibition of InhA Activity, but Not KasA Activity, Induces Formation of a KasA-containing Complex in MycobacteriaPublished by Elsevier BV ,2003
- Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosisMolecular Microbiology, 2002
- Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosisMolecular Microbiology, 2000
- Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by IsoniazidScience, 1998
- Multidrug-Resistant Mycobacterium tuberculosis: Molecular PerspectivesEmerging Infectious Diseases, 1998
- Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistanceAIDS, 1997
- Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular studyThe Lancet, 1994
- inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosisScience, 1994
- Tuberculosis: Commentary on a Reemergent KillerScience, 1992
- The lipids ofMycobacterium tuberculosis BCG: Fractionation, composition, turnover and the effects of isoniazidIrish Journal of Medical Science, 1970